paroxetine has been researched along with sulpiride in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 13 (56.52) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bach, FW; Ekman, R; Langemark, M; Olesen, J; Rehfeld, JF; Schifter, S | 1 |
| Langemark, M; Olesen, J | 1 |
| Campbell, AD; Erwin, VG; Jones, BC; Womer, DE | 1 |
| Fujiseki, Y; Inagaki, C; Kinoshita, T; Okugawa, G; Omori, K; Suzukawa, J | 1 |
| Cassano, GB; Jori, MC | 1 |
| Bogetto, F; Gandolfo, S; Maina, G; Vitalucci, A | 1 |
| Bogetto, F; Marchiaro, L; Rasetti, R; Rivoira, E; Rocca, P | 1 |
| Arai, H; Kumagai, R; Nagata, T; Ohnuma, T | 1 |
| Argyropoulos, S; Hale, AS; Willner, P | 1 |
| Kashima, H; Nomura, K; Suzuki, T; Takeuchi, H; Uchida, H; Watanabe, K | 1 |
| Magalhães, PV | 1 |
| Ikenouchi-Sugita, A; Nakamura, J; Yoshimura, R | 1 |
| Kashima, H; Suzuki, T; Uchida, H; Watanabe, K | 1 |
| Audi, EA; Biesdorf de Almeida, C; de Mello, JC; Klein, T; Roncon, CM | 1 |
| Abaitua, I; Alonso-Ferreira, V; Hens, MJ; Posada de la Paz, M; Villaverde-Hueso, A | 1 |
1 review(s) available for paroxetine and sulpiride
| Article | Year |
|---|---|
[Review of pharmacological efficacies and side effects of antidepressants].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Fluvoxamine; Humans; Imipramine; Maprotiline; Paroxetine; Sulpiride; Trazodone | 2007 |
8 trial(s) available for paroxetine and sulpiride
| Article | Year |
|---|---|
Effect of sulpiride or paroxetine on cerebrospinal fluid neuropeptide concentrations in patients with chronic tension-type headache.
Topics: Adult; Aged; Basal Metabolism; Calcitonin Gene-Related Peptide; Cholecystokinin; Chronic Disease; Dopamine D2 Receptor Antagonists; Dynorphins; Female; Humans; Male; Middle Aged; Neuropeptides; Paroxetine; Somatostatin; Sulpiride; Tension-Type Headache | 1994 |
Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial.
Topics: Adult; Aged; Chronic Disease; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Muscle Contraction; Paroxetine; Pilot Projects; Sulpiride | 1994 |
Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Psychiatric Status Rating Scales; Sulpiride | 2002 |
Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
Topics: Amisulpride; Antipsychotic Agents; Burning Mouth Syndrome; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Sulpiride; Treatment Outcome | 2002 |
A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
Topics: Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Social Adjustment; Social Behavior; Sulpiride; Treatment Outcome | 2002 |
Dopaminergic mechanism of antidepressant action in depressed patients.
Topics: Adult; Affect; Case-Control Studies; Citalopram; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluoxetine; Humans; Male; Middle Aged; Motor Activity; Paroxetine; Receptors, Dopamine D2; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome | 2005 |
Combined treatment with sulpiride and paroxetine for accelerated response in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Paroxetine; Psychological Tests; Sulpiride; Time Factors; Treatment Outcome | 2005 |
Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Paroxetine; Psychiatric Status Rating Scales; Sulpiride | 2009 |
14 other study(ies) available for paroxetine and sulpiride
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice.
Topics: Animals; Benzamides; Benzazepines; Binding Sites; Carrier Proteins; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Limbic System; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nerve Tissue Proteins; Paroxetine; Pharmacogenetics; Pyrrolidines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Drug; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Sulpiride | 1993 |
Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Cells, Cultured; Desipramine; Dexamethasone; Gene Expression Regulation; Haloperidol; Hippocampus; Ketanserin; Mianserin; Neurons; Paroxetine; Phentolamine; Propranolol; Radioligand Assay; Rats; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Sulpiride; Transcription, Genetic; Tritium | 1999 |
Drug-related hyperprolactinemia.
Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; Hyperprolactinemia; Indoramin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride | 2003 |
Visual and auditory hallucinations with excessive intake of paroxetine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Auditory Perception; Brain; Female; Hallucinations; Humans; Japan; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride; Visual Perception | 2003 |
Open trials in psychiatry: comments on article by Uchida et Al.
Topics: Antidepressive Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Paroxetine; Sulpiride | 2007 |
Anxiolytic effects of a semipurified constituent of guaraná seeds on rats in the elevated T-maze test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Dopamine Agents; Escape Reaction; Locomotion; Male; Maze Learning; Metergoline; Panic; Paroxetine; Paullinia; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Seeds; Serotonin Agents; Sulpiride | 2011 |
Cost-effectiveness analysis of burning mouth syndrome therapy.
Topics: Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Cost-Benefit Analysis; Decision Trees; Dental Care; Drug Costs; Health Care Costs; Humans; Paroxetine; Sertraline; Sulpiride | 2012 |